Mainz Biomed announced that three German-based companies have selected ColoAlert into their respective corporate health programs.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on MYNZ:
- Mainz Biomed Expands Corporate Health Program for ColoAlert with the Addition of Three New Companies in Germany
- Mainz Biomed announces results of biomarker independent feasibility study
- Mainz Biomed Reports Positive Results from Feasibility Study Evaluating its Portfolio of Novel mRNA Biomarkers for Early Detection of Advanced Colorectal Adenomas
- Mainz Biomed to Present at Sidoti Virtual Investor Conference March 22-23
- Mainz Biomed enters partnership with Labor Staber in Germany